# Guardant Health, Inc. (GH) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Guardant Health, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/GH/mda/fy2025/): filed 2026-02-19; accession 0001576280-26-000013 (https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/GH/mda/fy2024/): filed 2025-02-20; accession 0001576280-25-000044 (https://www.sec.gov/Archives/edgar/data/1576280/000157628025000044/gh-20241231.htm)
- [FY 2023 MD&A](/company/GH/mda/fy2023/): filed 2024-02-22; accession 0001576280-24-000043 (https://www.sec.gov/Archives/edgar/data/1576280/000157628024000043/gh-20231231.htm)
- [FY 2022 MD&A](/company/GH/mda/fy2022/): filed 2023-02-23; accession 0001576280-23-000020 (https://www.sec.gov/Archives/edgar/data/1576280/000157628023000020/gh-20221231.htm)
- [FY 2021 MD&A](/company/GH/mda/fy2021/): filed 2022-02-24; accession 0001576280-22-000015 (https://www.sec.gov/Archives/edgar/data/1576280/000157628022000015/gh-20211231.htm)

Back to /company/GH/